Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and MetastasisHengbo Zhou, Heide L. Ford, Daniel P. Regan et al.|Cancer Research|2020Cited by 47
Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosisElena M. Kaftanovskaya, Alexander I. Agoulnik, Hooi Hooi Ng et al.|The FASEB Journal|2019Cited by 35
Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule AgonistsXin Hu, Alexander I. Agoulnik, Courtney Myhr et al.|Biochemistry|2016Cited by 29
Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290Zaohua Huang, Alexander I. Agoulnik, Courtney Myhr et al.|Frontiers in Endocrinology|2015Cited by 21
Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profileKenneth J. Wilson, Juan Marugán, Jingbo Xiao et al.|European Journal of Medicinal Chemistry|2018Cited by 17